World Library  
Flag as Inappropriate
Email this Article

Desoxy

Article Id: WHEBN0004888011
Reproduction Date:

Title: Desoxy  
Author: World Heritage Encyclopedia
Language: English
Subject: 2,4,5-Trimethoxyphenethylamine, 2C-G, 2C-E, 2C-D, 2C-I
Collection: Phenethylamines, Psychedelic Phenethylamines, Serotonin Receptor Agonists
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Desoxy

DESOXY
Names
IUPAC name
2-(3,5-Dimethoxy-4-methyl-phenyl)-ethylamine
Other names
3,5-Dimethoxy-4-methylphenethylamine
2-(3,5-Dimethoxy-4-methylphenyl)ethanamine
Identifiers
 Y
ChEMBL  Y
ChemSpider  Y
Jmol-3D images Image
Properties
C11H17NO2
Molar mass 195.26 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 Y  (: Y/N?)

4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.

Contents

  • Effects 1
  • Dosage 2
  • Legality 3
  • References 4
  • External links 5

Effects

The effects of DESOXY vary significantly from mescaline, despite their chemical similarity.

Dosage

A typical dosage is within the range of 40–120 mg and lasts 6–8 hours.[1]

Legality

In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.

DESOXY is also an isomer of 2C-D which would cause it to fall within the definitions outlined by the Federal Analogue Act

References

  1. ^  

External links

  • Alexander Shulgin, Jacob, P. Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs. NIDA Research Monograph 146 (Hallucinogens: An Update), 1994.
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.